Amgen (AMGN) options expected to be active after reporting Repatha data

Amgen (NASDAQ: AMGN) March call option implied volatility is at 90, March weekly is at 41, April is at 26; compared to its 52-week range of 16 to 30 into releasing data for its 27,564-patient Repatha cardiovascular outcomes study,

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Micron Technology (MU) call put ratio 1 call to 1 put into quarter results
• Visteon (VC) 354 contracts of June 120 calls as share price up 6%